FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080218122> ?p ?o ?g. }

• W2080218122 endingPage "947" @default.
• W2080218122 startingPage "941" @default.
• W2080218122 abstract "It is widely recognised that sorafenib inhibits a range of molecular targets in renal cell carcinoma (RCC). In this study, we aim to use patient-derived RCC xenografts to delineate the angiogenic and non-angiogenic molecular targets of sorafenib therapy for advanced RCC (aRCC).We successfully generated three patient RCC-derived xenografts in severe combined immunodeficient mice, consisting of three different RCC histological subtypes: conventional clear cell, poorly differentiated clear cell RCC with sarcomatoid changes, and papillary RCC. This study also used clear cell RCC cells (786-0/EV) harbouring mutant VHL to investigate the clonogenic survival of cells transfected with survivin sense and antisense oligonucleotides.All three xenografts retain their original histological characteristics. We reported that sorafenib inhibited all three RCC xenograft lines regardless of histological subtypes in a dose-dependant manner. Sorafenib-induced growth suppression was associated with not only inhibition of angiogenic targets p-PDGFR-β, p-VEGFR-2, and their downstream signalling pathways p-Akt and p-ERK, cell cycle, and anti-apoptotic proteins that include cyclin D1, cyclin B1, and survivin but also upregulation of proapoptotic Bim. Survivin knockdown by survivin-specific antisense-oligonucleotides inhibited colony formation and induced cell death in clear cell RCC cells.This study has shed light on the molecular mechanisms of sorafenib in RCC. Inhibition of non-angiogenic molecules by sorafenib could contribute in part to its anti-tumour activities observed in vivo, in addition to its anti-angiogenic effects." @default.
• W2080218122 created "2016-06-24" @default.
• W2080218122 creator A5030315966 @default.
• W2080218122 creator A5046678435 @default.
• W2080218122 creator A5047320385 @default.
• W2080218122 creator A5055007960 @default.
• W2080218122 creator A5057005417 @default.
• W2080218122 creator A5066564166 @default.
• W2080218122 creator A5082944397 @default.
• W2080218122 date "2011-03-01" @default.
• W2080218122 modified "2023-10-09" @default.
• W2080218122 title "Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model" @default.
• W2080218122 cites W1968867081 @default.
• W2080218122 cites W1999966467 @default.
• W2080218122 cites W2005821882 @default.
• W2080218122 cites W2005909927 @default.
• W2080218122 cites W2008565093 @default.
• W2080218122 cites W2014582878 @default.
• W2080218122 cites W2028466368 @default.
• W2080218122 cites W2070396671 @default.
• W2080218122 cites W2074881736 @default.
• W2080218122 cites W2079650395 @default.
• W2080218122 cites W2083887116 @default.
• W2080218122 cites W2098176107 @default.
• W2080218122 cites W2099088585 @default.
• W2080218122 cites W2103382643 @default.
• W2080218122 cites W2109768764 @default.
• W2080218122 cites W2112940666 @default.
• W2080218122 cites W2115785123 @default.
• W2080218122 cites W2118421998 @default.
• W2080218122 cites W2139583265 @default.
• W2080218122 cites W2140765540 @default.
• W2080218122 cites W2152772600 @default.
• W2080218122 cites W2172253185 @default.
• W2080218122 doi "https://doi.org/10.1038/bjc.2011.55" @default.
• W2080218122 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3065286" @default.
• W2080218122 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21407223" @default.
• W2080218122 hasPublicationYear "2011" @default.
• W2080218122 type Work @default.
• W2080218122 sameAs 2080218122 @default.
• W2080218122 citedByCount "27" @default.
• W2080218122 countsByYear W20802181222012 @default.
• W2080218122 countsByYear W20802181222013 @default.
• W2080218122 countsByYear W20802181222014 @default.
• W2080218122 countsByYear W20802181222015 @default.
• W2080218122 countsByYear W20802181222016 @default.
• W2080218122 countsByYear W20802181222017 @default.
• W2080218122 countsByYear W20802181222018 @default.
• W2080218122 countsByYear W20802181222019 @default.
• W2080218122 countsByYear W20802181222020 @default.
• W2080218122 countsByYear W20802181222021 @default.
• W2080218122 countsByYear W20802181222022 @default.
• W2080218122 countsByYear W20802181222023 @default.
• W2080218122 crossrefType "journal-article" @default.
• W2080218122 hasAuthorship W2080218122A5030315966 @default.
• W2080218122 hasAuthorship W2080218122A5046678435 @default.
• W2080218122 hasAuthorship W2080218122A5047320385 @default.
• W2080218122 hasAuthorship W2080218122A5055007960 @default.
• W2080218122 hasAuthorship W2080218122A5057005417 @default.
• W2080218122 hasAuthorship W2080218122A5066564166 @default.
• W2080218122 hasAuthorship W2080218122A5082944397 @default.
• W2080218122 hasBestOaLocation W20802181221 @default.
• W2080218122 hasConcept C121608353 @default.
• W2080218122 hasConcept C126322002 @default.
• W2080218122 hasConcept C142724271 @default.
• W2080218122 hasConcept C190283241 @default.
• W2080218122 hasConcept C199835354 @default.
• W2080218122 hasConcept C2775975398 @default.
• W2080218122 hasConcept C2777472916 @default.
• W2080218122 hasConcept C2778019345 @default.
• W2080218122 hasConcept C2778695046 @default.
• W2080218122 hasConcept C2780394083 @default.
• W2080218122 hasConcept C29537977 @default.
• W2080218122 hasConcept C502942594 @default.
• W2080218122 hasConcept C54355233 @default.
• W2080218122 hasConcept C55493867 @default.
• W2080218122 hasConcept C62112901 @default.
• W2080218122 hasConcept C71924100 @default.
• W2080218122 hasConcept C75217442 @default.
• W2080218122 hasConcept C86554907 @default.
• W2080218122 hasConcept C86803240 @default.
• W2080218122 hasConceptScore W2080218122C121608353 @default.
• W2080218122 hasConceptScore W2080218122C126322002 @default.
• W2080218122 hasConceptScore W2080218122C142724271 @default.
• W2080218122 hasConceptScore W2080218122C190283241 @default.
• W2080218122 hasConceptScore W2080218122C199835354 @default.
• W2080218122 hasConceptScore W2080218122C2775975398 @default.
• W2080218122 hasConceptScore W2080218122C2777472916 @default.
• W2080218122 hasConceptScore W2080218122C2778019345 @default.
• W2080218122 hasConceptScore W2080218122C2778695046 @default.
• W2080218122 hasConceptScore W2080218122C2780394083 @default.
• W2080218122 hasConceptScore W2080218122C29537977 @default.
• W2080218122 hasConceptScore W2080218122C502942594 @default.
• W2080218122 hasConceptScore W2080218122C54355233 @default.
• W2080218122 hasConceptScore W2080218122C55493867 @default.
• W2080218122 hasConceptScore W2080218122C62112901 @default.
• W2080218122 hasConceptScore W2080218122C71924100 @default.
• W2080218122 hasConceptScore W2080218122C75217442 @default.

• next